Insulin Delivery Devices Market 2020: Impact of COVID-19 Research Report By BD, B. Braun Melsungen AG, Insulet Corporation, Medtronic, Tandem Diabetes Care, Eli Lilly and Company, Biocon, Owen Mumford, Sanofi among others

The Insight Partners analysts forecasts the latest report on “Global Insulin Delivery Devices Market (Covid-19) Impact and Analysis by 2025”, according to report; The Insulin Delivery Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Insulin Delivery Devices Market.

The study provides details such as the market share, Market Insights, Strategic Insights, Segmentation and key players in the Insulin Delivery Devices Market.

The insulin delivery devices market accounted to US$ 11,869.0 Mn in 2017 and is expected to grow at a CAGR of 8.7% during the forecast period 2018 – 2025, to account to US$ 22,830.0 Mn by 2025.

Get Sample Report of Insulin Delivery Devices Market Report @ https://www.theinsightpartners.com/sample/TIPHE100000819/?openpr-10225
(*If you have any special requirements, please let us know and we will offer you the report as you want.)

Note – The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries. This report on ‘Insulin Delivery Devices Market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The reports also showcase market trends and forecast to 2025, factoring the impact of Covid -19 Situation.

Our Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology

The reports cover key developments in the Insulin Delivery Devices Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players.

Some of the Major Market Players Are:

BD
Novo Nordisk A/S
B. Braun Melsungen AG
Insulet Corporation
Medtronic
Tandem Diabetes Care, Inc.
Eli Lilly and Company
Biocon
Owen Mumford, Ltd.
Sanofi

Market Insights

Rapid Growth in the Geriatric Population

Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the globe. These population is growing exponentially worldwide. According to a report of United Nation (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 2050.

Increasing Technological Advancement in Insulin Delivery Devices

The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices. For instance, in September 2016, the FDA announced their first automatically automatic glucose monitoring device, Medtronic’s MiniMed 670G which is a hybrid closed looped system that provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. In addition, in July 2018, Abbott announced to have a FDA approval for the FreeStyle Libre 14 day Flash Glucose Monitoring system that allows people with diabetes to wear the sensor up to 14 days with high accuracy. These advancements are expected to offer increasing demand for the products, hence providing better share to the market players.

Product Insights

The global insulin delivery devices market by product was led by insulin pens segment. In 2017, the insulin pens segment held a largest market share of 31.3% of the insulin delivery devices market, by product. The segment is also expected to dominate the market in 2025, since they offer increasing ease of use; increasing patient satisfaction and adherence; accuracy for delivering small doses of insulin.

End User Insights

The insulin delivery devices market by end user was segmented into patients/homecare and hospitals & clinics. The patients/homecare segment held the largest share of the market, by end user. The segment is also likely to dominate during the forecast period, as it allows a patient to regulate as well as monitor the glucose levels as well as administer insulin at home.

Strategic Insights

Product approvals and agreements were observed as the most adopted strategy in global insulin delivery devices industry. Few of the product approvals and agreements made by the players in the market are listed below;

2018: In June, 2018, Medtronic received CE Mark for its MiniMed(TM) 670G Hybrid Closed Loop System.

2018: In February, 2018, Tandemand Rubin Medical signed an agreement for distribution of insulin pumps in Scandinavia.

MARKET SEGMENTATION

By Product

• Insulin Pens
o Reusable Insulin Pens
o Disposable Insulin Pens
• Insulin Pumps
o Tube Pumps
o Patch Pumps
• Insulin Syringes
• Pen Needles
o Standard Pen Needles
o Safety Pen Needles
• Others

By End User

• Patients/Homecare
• Hospitals & Clinics

The report analyses factors affecting the Insulin Delivery Devices Market from further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Insulin Delivery Devices Market in these regions.

Moreover, the report entails the estimate and analysis for the Insulin Delivery Devices Market on a global as well as regional level. The study provides historical data as well as the trending features and future predictions of the market growth. Further, the report encompasses drivers and restraints for the Insulin Delivery Devices Market growth along with its impact on the overall market development. In addition, the report provides an analysis of the accessible avenues in the market on a global level.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Insulin Delivery Devices Market based on various segments. It also provides market size and forecast estimates from the year 2018 to 2025 with respect to five major regions. The Insulin Delivery Devices Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Promising Regions & Countries Mentioned in The Insulin Delivery Devices Market Report:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East & Africa

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Major Features of Insulin Delivery Devices Market Report:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Insulin Delivery Devices market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global Insulin Delivery Devices market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Purchase a copy of Insulin Delivery Devices Market research report @ https://www.theinsightpartners.com/buy/TIPHE100000819/?openpr-10225

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.